Question 1

What is Insmed's P/S ratio?

Accepted Answer

Insmed (INSM) P/S ratio is 28.0× as of July 22, 2026. The ratio is calculated by dividing market capitalisation by trailing twelve-month revenue, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/S ratio calculated?

Accepted Answer

P/S = Market Capitalisation ÷ Trailing Twelve-Month (TTM) Revenue, or equivalently Share Price ÷ TTM Revenue Per Share. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/S ratio?

Accepted Answer

The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.

Question 4

What is a good P/S ratio for Insmed?

Accepted Answer

A "good" P/S depends heavily on profit margin and growth: software and other high-margin businesses often command 5–15× sales, while low-margin retailers and commodity producers typically trade below 1×. Compare against sector peers rather than absolute thresholds. For Insmed specifically, the relevant sector benchmark is the current sector median of 3.4×.

Question 5

Is Insmed's P/S ratio high or low?

Accepted Answer

Insmed's P/S ratio of 28.0× is above its own 5-year average of 25.9× and above the sector median of 3.4×. That places the current reading at the 60th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is Insmed's historical P/S ratio range?

Accepted Answer

In the available daily series, Insmed (INSM) P/S ratio has ranged from a low of 4.8× in 2008 to a high of 1218.6× in 2006. The 5-year average is 25.9× and the 5-year median is 17.7×.

Question 7

What was Insmed's P/S ratio in 2025?

Accepted Answer

Insmed (INSM) P/S ratio at the end of 2025 was 61.3×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month revenue figure available at that date.

Question 8

Why does Insmed's P/S ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (revenue). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$37.2B	$606M	61.3×	+27.3×	Dec 31, 2025
2024	$12.4B	$364M	34.0×	+19.3×	Dec 31, 2024
2023	$4.49B	$305M	14.7×	+3.9×	Dec 31, 2023
2022	$2.65B	$245M	10.8×	-6.3×	Dec 31, 2022
2021	$3.23B	$188M	17.1×	-3.6×	Dec 31, 2021
2020	$3.41B	$164M	20.7×	+5.1×	Dec 31, 2020
2019	$2.13B	$136M	15.6×	-87.1×	Dec 31, 2019
2018	$1.01B	$9.84M	102.7×	—	Dec 31, 2018
2017	$2.39B	$0.00	—	—	Dec 31, 2017
2016	$816M	$0.00	—	—	Dec 31, 2016
2015	$1.11B	$0.00	—	—	Dec 31, 2015
2014	$754M	$0.00	—	—	Dec 31, 2014
2013	$666M	$11.5M	57.9×	—	Dec 31, 2013
2012	$210M	$0.00	—	—	Dec 31, 2012
2011	$75.8M	$4.42M	17.2×	+0.0×	Dec 31, 2011
2010	$119M	$6.92M	17.1×	+7.5×	Dec 31, 2010
2009	$100M	$10.4M	9.7×	+4.9×	Dec 31, 2009
2008	$57.2M	$11.9M	4.8×	-8.6×	Dec 31, 2008
2007	$101M	$7.47M	13.5×	-75.9×	Dec 31, 2007
2006	$88.6M	$992K	89.3×	-1113.5×	Dec 31, 2006
2005	$158M	$131K	1202.9×	+480.8×	Dec 31, 2005
2004	$98.9M	$137K	722.1×	-38.1×	Dec 31, 2004
2003	$114M	$150K	760.2×	+752.8×	Dec 31, 2003
2002	$14.6M	$1.96M	7.5×	—	Dec 31, 2002


Zimmer Biomet Holdings (ZBH)	2.1×
AptarGroup (ATR)	2.1×
Becton, Dickinson and (BDX)	2.1×
Charles River (CRL)	1.9×
Quest Diagnostics (DGX)	1.9×
IQVIA (IQV)	1.7×
GE HealthCare (GEHC)	1.6×
Labcorp Holdings (LH)	1.6×
HCA Healthcare (HCA)	1.4×
Solventum (SOLV)	1.4×
Viatris (VTRS)	1.1×
UnitedHealth Group (UNH)	0.8×
Baxter International (BAX)	0.8×
DaVita (DVA)	0.7×
Henry Schein (HSIC)	0.6×
Universal Health Services (UHS)	0.6×
Elevance Health (ELV)	0.4×
Teladoc Health (TDOC)	0.4×
McKesson (MCK)	0.3×
Cigna (CI)	0.3×
CVS Health (CVS)	0.2×
Cardinal Health (CAH)	0.2×
Cencora (COR)	0.2×
Humana (HUM)	0.2×
Centene (CNC)	0.1×

P/S Ratio for Insmed (INSM) 2002-2026

P/S Ratio daily chart for Insmed (INSM)

Historical P/S Ratio for Insmed (INSM) from 2002 to 2025

About P/S Ratio at Insmed (INSM)

Insmed P/S Ratio by Year

Insmed P/S Ratio 2025: 61.3×

Insmed P/S Ratio 2024: 34.0×

Insmed P/S Ratio 2023: 14.7×

Insmed P/S Ratio 2022: 10.8×

Insmed P/S Ratio 2021: 17.1×

Sector peers by P/S Ratio — chart

Sector peers by P/S Ratio — table

Frequently asked questions

Insmed (INSM) Key Financials